• Je něco špatně v tomto záznamu ?

CLICK-chemoproteomics and molecular dynamics simulation reveals pregnenolone targets and their binding conformations in Th2 cells

S. Roy, S. Roy, B. Mahata, J. Pramanik, ML. Hennrich, AC. Gavin, SA. Teichmann

. 2023 ; 14 (-) : 1229703. [pub] 20231031

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000954

Pregnenolone (P5) is synthesized as the first bioactive steroid in the mitochondria from cholesterol. Clusters of differentiation 4 (CD4+) and Clusters of differentiation 8 (CD8+) immune cells synthesize P5 de novo; P5, in turn, play important role in immune homeostasis and regulation. However, P5's biochemical mode of action in immune cells is still emerging. We envisage that revealing the complete spectrum of P5 target proteins in immune cells would have multifold applications, not only in basic understanding of steroids biochemistry in immune cells but also in developing new therapeutic applications. We employed a CLICK-enabled probe to capture P5-binding proteins in live T helper cell type 2 (Th2) cells. Subsequently, using high-throughput quantitative proteomics, we identified the P5 interactome in CD4+ Th2 cells. Our study revealed P5's mode of action in CD4+ immune cells. We identified novel proteins from mitochondrial and endoplasmic reticulum membranes to be the primary mediators of P5's biochemistry in CD4+ and to concur with our earlier finding in CD8+ immune cells. Applying advanced computational algorithms and molecular simulations, we were able to generate near-native maps of P5-protein key molecular interactions. We showed bonds and interactions between key amino acids and P5, which revealed the importance of ionic bond, hydrophobic interactions, and water channels. We point out that our results can lead to designing of novel molecular therapeutics strategies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000954
003      
CZ-PrNML
005      
20240213093523.0
007      
ta
008      
240109e20231031sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2023.1229703 $2 doi
035    __
$a (PubMed)38022565
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Roy, Sougata $u Department of Biology, Ashoka University, Rajiv Gandhi Education City, Sonipat, Haryana, India
245    10
$a CLICK-chemoproteomics and molecular dynamics simulation reveals pregnenolone targets and their binding conformations in Th2 cells / $c S. Roy, S. Roy, B. Mahata, J. Pramanik, ML. Hennrich, AC. Gavin, SA. Teichmann
520    9_
$a Pregnenolone (P5) is synthesized as the first bioactive steroid in the mitochondria from cholesterol. Clusters of differentiation 4 (CD4+) and Clusters of differentiation 8 (CD8+) immune cells synthesize P5 de novo; P5, in turn, play important role in immune homeostasis and regulation. However, P5's biochemical mode of action in immune cells is still emerging. We envisage that revealing the complete spectrum of P5 target proteins in immune cells would have multifold applications, not only in basic understanding of steroids biochemistry in immune cells but also in developing new therapeutic applications. We employed a CLICK-enabled probe to capture P5-binding proteins in live T helper cell type 2 (Th2) cells. Subsequently, using high-throughput quantitative proteomics, we identified the P5 interactome in CD4+ Th2 cells. Our study revealed P5's mode of action in CD4+ immune cells. We identified novel proteins from mitochondrial and endoplasmic reticulum membranes to be the primary mediators of P5's biochemistry in CD4+ and to concur with our earlier finding in CD8+ immune cells. Applying advanced computational algorithms and molecular simulations, we were able to generate near-native maps of P5-protein key molecular interactions. We showed bonds and interactions between key amino acids and P5, which revealed the importance of ionic bond, hydrophobic interactions, and water channels. We point out that our results can lead to designing of novel molecular therapeutics strategies.
650    12
$a pregnenolon $x metabolismus $x farmakologie $7 D011284
650    12
$a Th2 buňky $x metabolismus $7 D018418
650    _2
$a simulace molekulární dynamiky $7 D056004
650    _2
$a steroidy $7 D013256
650    _2
$a transportní proteiny $x metabolismus $7 D002352
655    _2
$a časopisecké články $7 D016428
700    1_
$a Roy, Sudeep $u Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czechia
700    1_
$a Mahata, Bidesh $u Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
700    1_
$a Pramanik, Jhuma $u Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
700    1_
$a Hennrich, Marco L $u Structural and Computational Biology Unit, European Molecular Biology Laboratory, EMBL, Heidelberg, Germany $u Cellzome, a GlaxoSmithKline (GSK) company, Genomic Sciences, Pharma R&D, Heidelberg, Germany
700    1_
$a Gavin, Anne-Claude $u Department for Cell Physiology and Metabolism, Centre Medical Universitaire, University of Geneva, Geneva, Switzerland $u Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
700    1_
$a Teichmann, Sarah A $u Cellular Genetics, Wellcome Sanger Institute, Cambridge, United Kingdom $u Theory of Condensed Matter, Cavendish Laboratory, Cambridge, United Kingdom
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 14 (20231031), s. 1229703
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38022565 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093520 $b ABA008
999    __
$a ok $b bmc $g 2049529 $s 1210648
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1229703 $e 20231031 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace